Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
62 results about "Lipid fraction" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Process for production of omega-3 rich marine phospholipids from krill
InactiveUS20100143571A1Quality improvementBroaden applicationMetabolism disorderOrganic compound preparationLipid formationKrill
The present disclosure relates to a process for preparing a substantially total lipid fraction from fresh krill, a process for separating phospholipids from the other lipids, and a process for producing krill meal.
Owner:PRONOVA BIOPHARMA NORGE
Bone graft material incorporating demineralized bone matrix and lipids
InactiveUS6565884B2Good osteoinductivityEasy to operateBiocidePowder deliveryHydrophilic polymersVitamin C
Owner:BIOMET MFG CORP
Sea cucumber carotenoid lipid fractions and process
InactiveUS6055936AThe material is lowPromote recoveryNervous disorderHydrolysed protein ingredientsLipid formationCarotenoid
Processing methods and compositions of matter are disclosed for lipid fractions of sea cucumber intestinal mass and body wall tissue suitable for the healthfood industry and aquaculture feed pigment industry. A process and composition of matter description for obtaining a high protein de-lipidized, de-odorized meal is also disclosed.
Owner:COLLIN PETER DONALD
Peroxisome biogenesis factor protein (PEX) disruptions for altering polyunsaturated fatty acids and total lipid content in oleaginous eukaryotic organisms
InactiveUS20090117253A1Lipid content in PEX-disrupted can be increased and decreasedFungiNervous disorderBiotechnologyOrganism
Methods of increasing the amount of polyunsaturated fatty acids (PUFAs) in the total lipid fraction and in the oil fraction of PUFA-producing, oleaginous eukaryotes, accomplished by modifying the activity of peroxisome biogenesis factor (Pex) proteins. Disruptions of a chromosomal Pex3 gene, Pex10p gene or Pex16p gene in a PUFA-producing, oleaginous eukaryotic strain resulted in an increased amount of PUFAs, as a percent of total fatty acids and as a percent of dry cell weight, in the total lipid fraction and in the oil fraction of the strain, as compared to the parental strain whose native Pex protein was not disrupted.
Owner:EI DU PONT DE NEMOURS & CO
Biodegradation process and composition
Disclosed are novel microbial compositions and biodegradation processes to treat marine animal or marine animal by-products to produce solid, liquid and lipid fractions that contain useful compounds.
Owner:AMERICAN CHEM CORP
Process for production of omega-3 rich marine phospholipids from krill
InactiveCN101652462AAvoid oxidative stressMetabolism disorderFatty-oils/fats refiningPhospholipidKrill
Owner:PRONOVA BIOPHARMA NORGE
Liquid Concentrated Formula
The invention pertains to a liquid complete nutritional composition suitable for feeding cachectic patients, having an energy density of at least 1.45 kcal / ml. The composition comprises a protein fraction in an amount of 7.8-12 g per 100 ml, a carbohydrate fraction, and a lipid fraction. At least 70 wt. % of the protein fraction can be obtained by demineralising milk, e.g. by ultrafiltration. The carbohydrate fraction (17-27 g per 100 ml) can comprise 0-35 wt. % of sucrose, 15-45 wt. % of other non-reducing mono-, di- and / or tri-saccharides, especially trehalose, 5-50 wt. % of other mono-and disaccharides and 5-40 wt. % of tri- and higher saccharides. The product is suitably packaged in small volumes (10-150 ml).
Owner:NUTRICIA
Nutritional compositions containing structured fat globules and uses thereof
ActiveUS20170231262A1Promote digestionVitamin food ingredientsOther dairy technologyChemical compositionCholesterol
The present disclosure relates to a lipid source for nutritional compositions, comprising an enriched lipid fraction which comprises structured fat globules. The enriched lipid fraction provides fat globules having a desired size and fatty acid composition and may be stabilized by components such as phospholipids, cholesterol, milk-fat globule membrane protein and combinations thereof. Additionally, the disclosure relates to methods of supporting lipid digestion in a pediatric subject by providing a nutritional composition comprising an enriched lipid fraction having structured fat globules that are more accessible to lipases. The chemical composition, size and structure of the fat globules may improve digestion. The disclosed nutritional compositions may provide additive and or / synergistic beneficial health effects.
Owner:MEAD JOHNSON NUTRITION
Biodegradation process and composition
Disclosed are novel microbial compositions and biodegradation processes to treat marine animal or marine animal by-products to produce solid, liquid and lipid fractions that contain useful compounds.
Owner:AMERICAN CHEM CORP
Process for the isolation of Z and E gugulsterones from aerial branches of Commiphora wightii (guggul)
A process for the isolation of a lipid fraction containing Z & E guggulsterones useful as cholesterol lowering drug, which comprises soaking / soxhlet extracting the powdered aerial part of the plant C. wightii with a non polar solvent, filtering / deanting the extract, soaking the material again in a polar solvent, filtering and concentrating the extracted material under reduced pressure as to obtain a thick viscous extract, and subjecting the thick viscous extract to gel filteration / silica gel chromatography to obtain Z & E ketosteroid containing lipid fraction exhibiting hypolipidemic activity.
Owner:COUNCIL OF SCI & IND RES
Biodegradation Process and Composition
Owner:AMERICAN CHEM CORP
Process for the isolation of a phospholipid
ActiveUS8828447B2Easy to handleQuantity minimizationAnthropod material medical ingredientsFatty-oils/fats refiningLong chain fatty acidFatty acids.polyunsaturated
The present invention relates to processes for the isolation of a phospholipid and for producing a polyunsaturated, long-chain fatty acids (PUFA)-enriched fraction from a fish oil comprising the steps of —providing a fish oil containing lipids and phospholipids; —mixing the fish oil with a polar solvent; —centrifuging the mixture of the fish oil and the polar solvent to separate a polar fraction from a lipid fraction; —isolating a phospholipid from the polar fraction or isolating a PUFA-enriched fraction from the polar fraction. The fish oil may be provided by —extracting a fish material with an extractant solvent; —removing the extractant solvent to provide the fish oil; —optionally subjecting the fish oil to a solid-liquid separation. The isolated phospholipids and PUFA's may be used as additives for functional foods, as a dietary supplement and for pharmaceutical application.
Owner:POLAR OMEGA
Nutritional composition for improving muscle function and daily activity
InactiveCN102143693AOrganic active ingredientsMuscular disorderOMEGA-3 POLYUNSATURATED FATTY ACIDSMammal
The invention relates to a nutritional composition comprising (a) at least 18 en% of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt% of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least an Omega-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving dailyactivity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.
Owner:NV NUTRICIA
Nutritional composition for improving mammalian immune system
ActiveCN102131502AOrganic active ingredientsPeptide/protein ingredientsOMEGA-3 POLYUNSATURATED FATTY ACIDSImmune modulator
The invention relates to a nutritional composition comprising (a) at least 18 en% of proteinaceous matter; (b) at least 12 wt% of leucine, based on total proteinaceous matter: (C) a lipid fraction comprising at least an omega-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid; and (d) an immune modulator; for improving the immune function in a mammal, preferably a human.
Owner:NUTRICIA
Manufacturing process for liposomal preparations
The present invention provides manufacturing processes for liposomal preparations. In accordance with the methods, a lipid fraction is dissolved in a water-miscible organic solvent. This solution comprising the lipid fraction can be added to and mixed with an aqueous solution under conditions to form a bulk liposomal preparation. Desirably, the preparation can include one or more active principals. The bulk liposomal preparation can be further processed as desired, for example, by size fractionation or reduction, removal of the water-miscible organic solvent, freeze-drying, or other treatment. The methods permit the production of liposomal formulations on a large or commercial scale.
Owner:NEOPHARM CO LTD
Method and apparatus for preparing novel liposome
ActiveUS20130069261A1Increase contentImprove loading efficiencyAntimycoticsSolvent extractionLaboratory scaleFreeze-drying
Disclosed is a method for preparing a liposome formulation. In the disclosed method, a lipid fraction is dissolved in an organic solvent. The solution including a bioactive component and the lipid fraction, together with a carrier, is put in a reaction vessel, and a supercritical fluid is introduced thereto, so as to prepare particles coated with the bioactive component-lipid. The supercritical fluid is discharged by compression to obtain proliposome particles, and then the proliposome particles are hydrated by an aqueous solution including water so as to form a liposome solution. Preferably, the formulation may include one or more bioactive components. As required, the liposome formulation may be further processed by methods such as particle size reduction, removal of organic solvent, and freeze-drying. The preparation method can be easily carried out at a laboratory scale. Furthermore, the same method can be employed in liposome formulation preparation in mass production, or at a commercial scale.
Owner:BCWORLD PHARMA
Method and apparatus for preparing novel liposome
ActiveCN102781428AImprove stabilityIncrease contentBioreactor/fermenter combinationsAntimycoticsLipid formationLaboratory scale
Disclosed is a method for preparing a liposome formulation. In the disclosed method, a lipid fraction is dissolved in an organic solvent. The solution including a bioactive component and the lipid fraction, together with a carrier, is put in a reaction vessel, and a supercritical fluid is introduced thereto, so as to prepare particles coated with the bioactive component-lipid. The supercritical fluid is discharged by compression to obtain proliposome particles, and then the proliposome particles are hydrated by an aqueous solution including water so as to form a liposome solution. Preferably, the formulation may include one or more bioactive components. As required, the liposome formulation may be further processed by methods such as particle size reduction, removal of organic solvent, and freeze-drying. The preparation method can be easily carried out at a laboratory scale.; Furthermore, the same method can be employed in liposome formulation preparation in mass production, or at a commercial scale.
Owner:BC WORLD PHARM LTD
Nutritional Compositions Containing Structured Fat Globules and Uses Thereof
ActiveUS20140255539A1Promote digestionMilk preparationVitamin food ingredientsChemical compositionCholesterol
The present disclosure relates to a lipid source for nutritional compositions, comprising an enriched lipid fraction which comprises structured fat globules. The enriched lipid fraction provides fat globules having a desired size and fatty acid composition and may be stabilized by components such as phospholipids, cholesterol, milk-fat globule membrane protein and combinations thereof. Additionally, the disclosure relates to methods of supporting lipid digestion in a pediatric subject by providing a nutritional composition comprising an enriched lipid fraction having structured fat globules that are more accessible to lipases. The chemical composition, size and structure of the fat globules may improve digestion. The disclosed nutritional compositions may provide additive and or / synergistic beneficial health effects.
Owner:MEAD JOHNSON NUTRITION
Enteral composition for the prevention and/or treatment of sepsis
InactiveCN1802102AImprove stabilityAntibacterial agentsOrganic active ingredientsPhysiologyPhospholipid
Owner:NV NUTRICIA
Insecticidal Agents and Uses Thereof
InactiveUS20140100175A1Reduce in quantityPrevent intrusionBiocideSugar derivativesPhylum AscomycotaToxicology
The present invention provides insecticidal lipids and lipid fractions from fungi of the phylum Ascomycota, together with compositions comprising such lipids and lipid fractions and methods of preparing same. Methods for the biological control of insects, such as phytopathogenic insects, using the lipids and lipid fractions or compositions comprising said lipids optionally together with one or more insecticidal or entomopathogenic agents including entomopathogenic fungi, are also provided.
Owner:BIOTELLIGA HLDG
Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
The present disclosure relates to a nutritional composition comprising a fat source that includes an enriched lipid fraction derived from milk. The enriched lipid fraction may contain saturated fatty acids, trans-fatty acids, monounsaturated fatty acids, CLAs, BCFAs, cholesterol, milk fat globule membrane proteins, gangliosides, and mixtures thereof. The enriched lipid fraction may exhibit additive or synergistic beneficial health effects when consumed. The disclosure further relates to methods of providing a nutritional composition comprising an enriched lipid fraction to targeted subjects.
Owner:MEAD JOHNSON NUTRITION
Insecticidal lipid agents isolated from entomopathogenic fungi and uses thereof
Owner:BIOTELLIGA HLDG
Enteral composition for the prevention and/or treatment of sepis
InactiveUS20070190064A1Improve stabilityComposition is stableAntibacterial agentsOrganic active ingredientsPhospholipidEndocrinology
Enteral compositions and use thereof, which compositions contain proteins and lipids, for the prevention and / or treatment of sepsis; the lipid fraction being particularly rich in phospholipids.
Owner:NUTRICIA
Method for improving executive function
Owner:NV NUTRICIA
Method of making an anti-inflammatory composition
Owner:KUWAIT UNIV
Cosmetic Composition Comprising A Lipid Fraction From Vegetal Source And Anticrystaling Agent
Owner:NATURA COSMETICOS SA
Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction
InactiveUS20120021982A1Organic chemistryPeptide/protein ingredientsApolipoproteins ELeft ventricular diastolic dysfunction
The present invention features pharmaceutical compositions and methods of using the pharmaceutical compositions for treating left ventricular diastolic dysfunction. In particular, the pharmaceutical compositions include an apolipoprotein complex comprising a lipid fraction and a protein fraction.
Owner:INST DE CARDIOLOGIE DE MONTREAL
Manufacturing process for liposomal preparations
InactiveUS20090011001A1Good characterExtended shelf lifeBiocideOrganic active ingredientsOrganic solventWater insoluble
The present invention provides a manufacturing process for liposomal preparations comprising water-insoluble or hydrophobic active principals. In accordance with one aspect of the inventive method, at least one active principal and lipid fraction are dissolved in an organic solvent. This solution is then subjected to reduced pressure (vacuum) in a container with or with out inert packing to remove the organic solvent, thereby forming a puffy cake comprising the active principal or principals and lipid fraction. This puffy cake is then mixed with an aqueous solution, under controlled conditions suitable to form a bulk liposomal preparation. Because the active principal is imbedded in the lipid bilayer, removal of the aqueous solution is optional.
Owner:AHMAD ZAFEER +3
Method of making an Anti-inflammatory composition
In order to prepare an anti-inflammatory composition extracted from the skin of the Arabian Gulf catfish (Arius bilineatus (Valenciennes)), a gelatinous secretion is collected from the skin of the Arabian Gulf catfish. The gelatinous secretion is biologically active due to the presence of biologically active proteins and lipids. The lipids are extracted from the gelatinous secretion, and then are mixed into an inert dermatological cream. The inert dermatological cream serves as a carrier for the lipids. Preferably, the mixture includes approximately 0.2% to 0.8% of the lipids by weight. Either the total lipids may be used in the mixture, or the lipids, prior to mixing into the cream, may be fractionated into major lipid fractions.
Owner:KUWAIT UNIV
Lipid composition for improving brain function
The invention pertains to the use of a lipid fraction for the support of brain function. The lipid fraction comprises the medium-chain fatty acids at least 4 g hexanoic acid and / or at least 5 g octanoic acid, at least 1 g eicosapentaenoic acid, and in addition more than 0.4 g alpha - linolenic acid per 100 g fatty acids of the lipid fraction.
Owner:NUTRICIA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com